International Stem Cell Corp. (ISCO) Subsidiary Enters Chinese Market with Cell-Based Cosmetic Products
International Stem Cell Corp., a California-based biotechnology company focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products, today announced its cosmoseutical subsidiary Lifeline Skin Care (www.lifelineskincare.com) has signed an agreement to distribute its anti-aging skin care products in China using the extended clinical network of one of the largest pharmaceutical companies in China, Sinopharm Group.
Lifeline engages in the development, manufacturing, and commercialization of advanced skin care products based on growth factors and peptides derived from human parthenogenetic stem cells. The products, developed by ISCO’s scientific team in collaboration with renowned skin care experts, deliver anti-aging benefits, resulting in younger-looking skin. The products are available for purchase through medical offices and luxury spas across the United States and from www.lifelineskincare.com.
Annual sales of cosmetic products in mainland China are estimated at $8 billion. The large population of affluent consumers and surging demand for consumer products provide ISCO with solid opportunity. Now growing at an annual rate of over 10%, the Chinese market is an ideal choice for further growth. Together with its Chinese partner Brilliant Sunrise SBC, which is responsible for importation and regulatory approvals, Lifeline will offer its breakthrough anti-aging skin care products in China’s largest and most respected hospitals, spas, and through online channels.
“We’re excited to partner with the Lifeline Skin Care brand of science-based skin care and to bring their cutting edge technology to China. Lifeline is a leader in an emerging field that will change how serious cosmetic brands approach skin care. By rolling out the products in channels such as Shanghai’s 9th People Hospital and Hua Shan Hospital, which have some of the best cosmetic surgery and skin care centers in China, we aim to introduce the product in a way that highlights Lifeline Skin Care’s unique value proposition,” stated Nicole Sha, Co-founder of Brilliant Sunrise SBC.
“We are extremely pleased that we can now offer our stem cell-based anti-aging skin care products in China. By using this network of healthcare centers and spas, we are making our unique products available to consumers through a credible provider that they already trust and have a relationship with,” added Donna Queen, President of Lifeline Skin Care.
For additional information on ISCO, visit the company’s website at www.InternationalStemCell.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net